Private donor

The LCSB takes on challenges that most pharma concerns try to avoid because of their lack of profitability, such as research on rare diseases. Three years ago, I started to support the LCSB’s research in the field of Batten Disease, a rare disease that affects children. I am glad to be able to contribute to the Luxembourg research efforts in this manner.